SARS-CoV-2 triggers antibodies from previous coronavirus infections
A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
List view / Grid view
A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
In this article, Drug Target Review’s Hannah Balfour discusses three of the latest developments in imaging for disease research and drug development.
Using a new compound mixture, researchers have created adaptive and regenerative stem cells from human fat cells.
An antisense oligonucleotide has been developed by researchers to inhibit IRF4 as a potential strategy to treat multiple myeloma.
A new form of CAR T-cell therapy has shown promise in mice models to treat blood cancers; this article delves into the development behind the therapy.
Researchers have shown that CBD can kill Gram-negative bacteria, which could lead to the first new class of antibiotics for resistant bacteria in 60 years.
Researchers have revealed how the most severe cases of G6PD deficiency occur, which could help scientists design new drugs for the disease.
Using synthetic chemistry, researchers have fused hydrophobic adjuvants with water-soluble proteins to create a new type of vaccine.
Scientists have found that a new knee injection using nanomedicine could prevent the effects of osteoarthritis.
A study has said that restoring a particular protein's activity could be a new therapeutic strategy to treat glioblastoma.
Researchers have isolated a compound from I. viscosa that kills the "brain-eating" amoebae from primary amoebic meningoencephalitis (PAM).
Scientists have developed an inhaled treatment for asthma that prevents excess mucus from building up in mice.
In this article, we outline three recent studies that have advanced the potential uses of CRISPR in the biomedical field.
A new protein-based nanoparticle vaccine protected mice against a variety of coronaviruses, researchers have shown.
Tests in Alzheimer's disease mouse models have shown that hydrogen sulphide can improve cognitive and motor function by 50 percent.